Bubbiano, Italy

Silvia Comis

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Nerviano Medical Services S.r.l.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvia Comis. Retrieved from https://idiyas.com/inventor/silvia-comis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Silvia Comis: Innovator in Cancer Treatment

Introduction

Silvia Comis is a notable inventor based in Bubbiano, Italy. She has made significant contributions to the field of cancer treatment, particularly through her innovative research and development of therapeutic agents.

Latest Patents

Silvia Comis holds a patent for the "Use of kinase inhibitor for the treatment of thymoma." This invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA inhibitor for use in the treatment of thymoma and thymic carcinoma. The compound can be administered together with one or more cytotoxic or cytostatic agents. She has 1 patent to her name.

Career Highlights

Throughout her career, Silvia has worked with prominent companies in the pharmaceutical sector, including Nerviano Medical Services S.r.l. and Nerviano Medical Sciences S.r.l. Her work has focused on developing innovative treatments that enhance patient outcomes in oncology.

Collaborations

Silvia has collaborated with esteemed colleagues such as Bernard Laffranchi and Marina Ciomei, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Silvia Comis is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. Her contributions continue to influence the field and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…